as on February 14, 2026 at 7:59 am IST
Day's Low
Day's High
2.31%
Downside
2.96%
Upside
52 Week's Low
52 Week's High
70.47%
Downside
23.83%
Upside
Check Enanta Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$413.5M
EPS (TTM)
-2.35
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.66%
PE Ratio (TTM)
-2.39
Industry PE ratio
-2.2238461538461536
PEG Ratio
0EBITDA
-68.2M
Revenue (TTM)
67.0M
Profit Margin
-106.80%
Return On Equity TTM
-60.01%
Track how Enanta Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Enanta Pharmaceuticals Inc in the last 5 years
Lowest (-15.76x)
December 31, 2021
Today (-2.39x)
February 13, 2026
Industry (-2.22x)
February 13, 2026
Highest (-1.36x)
March 31, 2025
Today’s Price to Earnings Ratio: -2.39x
Compare market cap, revenue, PE, and other key metrics of Enanta Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $413.5M | -73.03% | -2.39 | -106.80% | |
| BUY | $118.3B | 117.32% | 32.46 | 31.35% | |
| NA | $38.9B | NA | 662.77 | 1.38% | |
| BUY | $42.5B | 95.34% | 1109.48 | 1.36% | |
| BUY | $82.4B | 61.37% | 18.8 | 31.41% |
The Enanta Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Enanta Pharmaceuticals Inc investment value today
Current value as on today
₹1,89,296
Returns
₹89,296
(+89.3%)
Returns from Enanta Pharmaceuticals Inc Stock
₹84,667 (+84.67%)
Dollar Returns*
₹4,629 (+4.63%)
Based on 14 analysts
64.29%
Buy
28.57%
Hold
7.14%
Sell
Based on 14 analysts, 64.29% of analysts recommend a 'BUY' rating for Enanta Pharmaceuticals Inc. Average target price of $19.25
Get share price movements and forecasts by analysts on Enanta Pharmaceuticals Inc.
What analysts predicted
28.05%UPSIDE
Target Price
$19.25
Current Price
$13.85
Analyzed by
14 Analysts
Target
$19.25
Enanta Pharmaceuticals Inc target price $19.25, a slight upside of 28.05% compared to current price of $13.85. According to 14 analysts rating.
Search interest for Enanta Pharmaceuticals Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:33% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 29 November
Sun, 05:52 AM
-Enanta Pharmaceuticals' common stock and options are under a Lock-Up Agreement ending on November 30, 2025.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -18.7M → -11.93M (in $), with an average increase of 56.6% per quarter
Best in 1 Year
![]()
In the last 1 year, ENTA has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 15.12M → 18.61M (in $), with an average increase of 18.8% per quarter
Price Rise
![]()
In the last 6 months, ENTA stock has moved up by 73.0%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 45.1% return, outperforming this stock by 117.5%
| Organisation | Enanta Pharmaceuticals Inc |
| Headquarters | 4 Kingsbury Avenue, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Jay R. Luly Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Harry R. Trout III | VP of Finance & Interim Principal Financial Officer |
Ms. Jennifer Viera | Executive Director of Investor Relations & Corporate Communications |
Mr. Matthew P. Kowalsky J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Nathaniel S. Gardiner J.D. | Consultant |
Ms. Tara Lynn Kieffer Ph.D. | Chief Product Strategy Officer |
Mr. Brendan Luu | Chief Business Officer |
Dr. Scott T. Rottinghaus M.D. | Chief Medical Officer |
Dr. Yat Sun Or Ph.D. | Chief Scientific Officer |
Dr. Jay R. Luly Ph.D. | President, CEO & Director |
Enanta Pharmaceuticals Inc share price today is $13.85 as on at the close of the market. Enanta Pharmaceuticals Inc share today touched a day high of $14.26 and a low of $13.53.
Enanta Pharmaceuticals Inc share touched a 52 week high of $17.15 on and a 52 week low of $4.09 on . Enanta Pharmaceuticals Inc stock price today i.e. is closed at $13.85,which is 19.24% down from its 52 week high and 238.63% up from its 52 week low.
Enanta Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Enanta Pharmaceuticals Inc (ENTA) shares with as little as ₹90.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.40 in Enanta Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enanta Pharmaceuticals Inc share’s latest price of $13.85 as on February 14, 2026 at 2:29 am IST, you will get 0.7220 shares of Enanta Pharmaceuticals Inc. Learn more about
fractional shares .
Enanta Pharmaceuticals Inc stock has given -73.03% share price returns and 24.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?